American investor and entrepreneur
POPULARITY
Categories
elcome back to the Sisterhood of S.W.E.A.T. Podcast — the show that's all about building strength, resilience, and success from the inside out. Today, we're diving into the world of entrepreneurship, investing, and breaking barriers with none other than Rashaun Williams. You may know him as a Guest Shark on ABC's Shark Tank, but his influence stretches far beyond the TV screen. As founder and Chief Investment Officer of Harbinger Sports Partners — a $750 million private equity fund co-launched with Mark Cuban and Steve Cannon — Rashaun is changing the game by investing in professional sports teams. With over 170 investments, 50 exits, and early stakes in companies like Robinhood, Coinbase, Ring, and Lyft, his track record speaks for itself. But Rashaun's passion goes beyond deals — he's committed to financial literacy and giving back through the Kemet Institute, which provides free entrepreneurship and life skills to underserved communities. Today, we'll hear his journey from Wall Street to Shark Tank, the lessons he's learned along the way, and what it really takes to build wealth that lasts. Get ready for an episode packed with inspiration, strategy, and some serious Shark wisdom. Connect with Rashun: Instagram: https://www.instagram.com/rashaun_williams/?hl=en Instagram+1 LinkedIn: https://www.linkedin.com/in/rashaunlwilliams LinkedIn+1 Twitter / X: https://twitter.com/RashaunWilliams How you can stay in touch with Linda: Website Facebook Twitter Instagram Pinterest YouTube SoundCloud "Proud Sponsors of the Sisterhood of S.W.E.A.T" Essential Formulas
Bill Maher and his guests answer viewer questions after the show. (Originally aired 10/17/25) Learn more about your ad choices. Visit podcastchoices.com/adchoices
Leaders Of Transformation | Leadership Development | Conscious Business | Global Transformation
How do you turn a personal frustration into a $75 million brand—with no experience in the industry? In this episode of Leaders of Transformation, host Nicole Jansen interviews Justin Baer, founder of Collars & Co., who transformed a simple idea—a dress-collar polo shirt—into one of the fastest-growing luxury menswear brands in America. With no background in fashion and a long history of entrepreneurial experiments (and failures), Justin shares how he built a multimillion-dollar brand through relentless action, rapid testing, and the courage to launch imperfect ideas. His story of Shark Tank success and partnership with Mark Cuban reveals how persistence, timing, and customer feedback can turn a simple product into a household name. You'll learn: How to identify business opportunities from everyday frustrations Why “done” is better than “perfect” when launching a new product The power of storytelling and viral marketing (including the TikTok video made by his daughter) How to scale fast while staying true to your brand vision What it takes to go from side hustle to a $75 million business in just three years If you're an entrepreneur, innovator, or aspiring business leader, this conversation will inspire you to take action—before you feel ready—and trust the process of learning, testing, and growing along the way.
“When I was in medical school, no one had even heard of mitochondrial disease. Today, every student who graduates here knows what it is and has seen a patient with it,” says Dr. Mary Kay Koenig, director of the Center for the Treatment of Pediatric Neurodegenerative Disease at UTHealth Houston McGovern Medical School. That remarkable change in awareness has been accompanied by advances in genetic sequencing, the development of clinical guidelines, and the emergence of potential treatments in some forms of mitochondrial disease. In fact, Dr. Koenig's multidisciplinary team at UTHealth's Mitochondrial Center of Excellence has been a key player in clinical trials that may yield the first FDA-approved treatments for it. As you'll learn in this Year of the Zebra conversation with host Michael Carrese, her work in neurodegenerative diseases also includes tuberous sclerosis, where advanced therapies have replaced the need for repeated surgeries, and Leigh Syndrome, which has seen improvements in diagnoses and supportive therapies leading to better quality of life for patients. Tune in as Dr. Koenig reflects on an era of progress in the space, the rewards of balancing research, teaching and patient care, and the need for more clinicians to center listening, humility and honesty in their approach to caring for rare disease patients and their families.Mentioned in this episode:Mitochondrial Center of ExcellenceCenter for the Treatment of Pediatric Neurodegenerative Disease If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast
Dave Rubin of The Rubin Report talks about Bill Maher still showing some TDS symptoms, but also surprising Mark Cuban and the Real Time with Bill Maher audience by pointing out the hypocrisy of pro-Palestine protesters for ignoring the killing of Palestinians by Hamas; a look at the baby-boomer-led “No Kings” protests that you won't see on CNN; a resurfaced clip of Mike Bloomberg calling out Bernie Sanders' liberal hypocrisy to his face that's now going viral; Mike Johnson pointing out to This Week's Jonathan Karl that the “No Kings” protests accidentally proved the anti-Trump protesters are delusional; The View's Joy Behar and Sunny Hostin claiming the “No Kings” protests are proof Americans are worried about authoritarianism; Zohran Mamdani's failed attempt to explain how he would pay for free buses in New York City; Real Time with Bill Maher guests Mark Cuban and Andrew Ross Sorkin being shocked by Maher's warning to Democrats supporting Zohran Mamdani and turning against capitalism; and much more. Today's Sponsors: Perplexity AI - Use the Comet web browser, the new AI-web browser from Perplexity, that will completely change the way you are able to interact with your browser. Download Perplexity's new AI-web browser, Comet, by heading to: https://pplx.ai/RUBIN Plus, right now when you download Comet - you get a month of Rumble Premium for free! Covepure - A countertop water purifier certified to remove up to 99.9% of impurities including fluoride, PFAs, fertilizer runoff, pharmaceuticals, and others. Go to https://covepure.com/rubin to get $200 off for a limited time only! Morgan & Morgan - Morgan & Morgan is America's Largest Injury Law Firm, with over 1,000 attorneys operating in all 50 states. Go to: https://ForThePeople.com/Rubin
Sara Eisen, David Faber, and Carl Quintanilla kicked off the hour looking at fresh data on the China front before breaking down the market picture with Charles Schwab's Chief Investment Strategist Liz Ann Sonders. Plus: why gold and stocks are partying together - according to market veteran Ruchir Sharma, who broke down the rare correlation and why it could lead to an "unpleasant surprise" for investors... and what to do with Netflix shares - ahead of results tomorrow. Also in focus: Mark Cuban telling CNBC that the Trump administration deserves credit for its efforts to reduce drug prices - hear his exclusive comments, this hour... Along with the latest on the huge internet outage sending a number of high profile websites dark this morning... and the regulatory win sending Boeing shares to fresh highs. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Kirsten Maitland is the co-founder of Rebel Cheese, an award-winning Austin-based vegan cheese brand backed by Shark Tank investor Mark Cuban. A former U.S. Navy veteran and Microsoft agile coach, Kirsten brings her background in tech innovation to reimagine plant-based dairy through traditional cheesemaking techniques and smart Ecommerce strategy.After leaving a stable four-day tech career to pursue purpose over comfort, Kirsten built Rebel Cheese from a six-bottle wine fridge experiment into a nationally recognized brand featured by The New York Times. From launching DTC overnight during COVID to scaling through broken shipments and real-time customer feedback, her journey reveals what it takes to grow authentically while staying true to your values.Whether you're building a mission-driven CPG company or refining your feedback loop before scaling, Kirsten shares a masterclass in transforming curiosity and conviction into sustainable growth.In This Conversation We Discuss:[00:03] Intro[00:55] Bringing tradition into modern food innovation[01:30] Turning passion for food into a scalable concept[02:34] Validating a product through emotional connection[03:33] Turning crisis into new growth channels[04:44] Fixing packaging with help from early partners[06:03] Shipping curated boxes to customers' doors[07:00] Selling out with zero ads or paid marketing[08:00] Turning online orders into lasting connections[08:58] Delaying advertising to protect cash flow[10:21] Stay updated with new episodes[10:31] Learning to sustain momentum after viral moments[12:24] Studying investor dynamics before pitching[12:53] Episode Sponsors: Electric Eye & Heatmap[15:32] Launching fast to gather real customer feedback[18:01] Leveraging AI agents to save time and moneyResources:Subscribe to Honest Ecommerce on YoutubePlant-based cheese you'll actually love rebelcheese.com/Follow Kirsten Maitland linkedin.com/in/kirstenmaitlandSchedule an intro call with one of our experts electriceye.io/connectClear, real-time data built for ecommerce optimization heatmap.com/honestIf you're enjoying the show, we'd love it if you left Honest Ecommerce a review on Apple Podcasts. It makes a huge impact on the success of the podcast, and we love reading every one of your reviews!
#636 What if a simple TikTok video filmed by a seven-year-old could launch a million-dollar business? Or lead to a deal on Shark Tank? In this episode, host Kirsten Tyrrel sits down with Justin Baer, the founder and CEO of Collars & Co., a Mark Cuban-backed menswear brand that's changing how professional men dress. Justin takes us behind the scenes of his entrepreneurial journey — from the initial idea sparked during COVID to scaling the business into a full menswear line. He shares how a simple TikTok video filmed by his seven-year-old daughter turned into $40,000 in sales in the first month, why being willing to fail is key to success, and how giving away your product for free can be a powerful market test. Whether you're launching a product or looking to refine your business strategy, Justin's insights on testing, scaling, and building relationships will give you the confidence to take the next step! (Original Air Date - 3/24/25) What we discuss with Justin: + How a TikTok video sparked $40K in sales + Testing product viability with consignment + Importance of being willing to fail + Scaling from one product to a full brand + Leveraging influencer and social proof marketing + Why giving away products can drive sales + Balancing product uniqueness vs. smart marketing + Building strong relationships with retailers + Transitioning from DTC to omnichannel strategy + Learning and adapting quickly as an entrepreneur Thank you, Justin! Check out Collars & Co. at CollarsandCo.com. Use coupon code MU to get 20% off your first order. Watch the video podcast of this episode! To get access to our FREE Business Training course go to MillionaireUniversity.com/training. And follow us on: Instagram Facebook Tik Tok Youtube Twitter To get exclusive offers mentioned in this episode and to support the show, visit millionaireuniversity.com/sponsors. Want to hear from more incredible entrepreneurs? Check out all of our interviews here! Learn more about your ad choices. Visit megaphone.fm/adchoices
Bill's guests are Arnold Schwarzenegger, Andrew Ross Sorkin, Mark Cuban (Originally aired 10/17/25) Learn more about your ad choices. Visit podcastchoices.com/adchoices
She started as a teenage radio DJ with big dreams and a love for loud music — and turned that passion into a powerhouse television career. On this episode of Takin’ a Walk, Katie Daryl joins the conversation to share her journey from spinning records in Phoenix to becoming the creative force behind AXS TV hits like The Top Ten Revealed and The World’s Greatest Tribute Bands. As the former Vice President of Programming, Katie reveals what it’s like building original rock-focused content, landing her first job by cold-calling Mark Cuban, and interviewing legends from Alice Cooper to Dionne Warwick. It’s a walk through decades of music, television, and fearless creativity with one of entertainment’s most dynamic storytellers.Support the show: https://takinawalk.com/See omnystudio.com/listener for privacy information.
Ben Schwartz, MD, MBA, wrote an article recently, and yeah, he makes a really compelling point. Dr. Schwartz wrote, “Ultimately, the most successful care models are those that create value inherently. The goal isn't simply cost arbitrage; it's creating a sustainable system that makes value attainable. Care delivery innovation is about more than optimizing for VC [venture capital] returns or maximizing operational efficiency.” For a full transcript of this episode, click here. If you enjoy this podcast, be sure to subscribe to the free weekly newsletter to be a member of the Relentless Tribe. That mention of value and how to achieve it for real—like, actually create a care model that delivers value inherently—is a great segue to introduce the show this week. It's a continuation of our mission/margin theme, and this week, we're talking about the margin part of the “no margin, no mission” cliché. So, taking this from the top, last week—and go back and listen to that show if you have not yet (and you can listen to both of these parts in no particular order; you do you)—but last week, we talked mission. That part about value and creating value inherently? The tie-in here to mission and margin could be a value equation, really. Like, mission divided by margin is how you calculate the value delivered (less carrier spread), but that's a whole other show with Cynthia Fisher (EP457). So, let me introduce my guest this week, who was also my guest last week: Dan Greenleaf, CEO of Duly, which is a multispecialty group in Chicago. So, last week Dan and I talked mission, as I said; but today we're talking margin, which is, again, gonna be the denominator of so many value equations. Last week in that mission show, quick review (or spoiler alert, depending on the order in which you may be listening to these shows), but last week, Dan Greenleaf broke mission, Duly's mission, into four quadrants. The four quadrants of mission being affordability, access, consumer experience, and quality. In this conversation today, the margin conversation, Dan Greenleaf emphasizes that achieving these four quadrants reduces friction for patients and clinicians that leads to not only better care outcomes but also financial sustainability (ie, margin). Margin can therefore be a function of mission. And again, as Dr. Ben Schwartz put it, “Ultimately, the most successful care models are those that create value inherently.” So, here we go. To be noted with one big fat fluorescent highlighter marker, a big part of this mission that comes up over and over again last week, it's about making prices reasonable and predictable and transparent for patients. Financial toxicity is a thing. Financial toxicity not only is clinical toxicity when so many people are delaying needed care. And look, I don't often quote Marjorie Taylor Greene, but recently she was in the New York Times and was quoted as saying, “The cost of health care is killing people.” This is what we should be focusing on. I just read the other day that one-third of adults in this country are currently delaying or forgoing care due to cost. One-third! Not one-third of low income or something like that. One-third of adults in this country are delaying or forgoing care due to fear of cost. In today's world, affordability and price transparency is part of what customer experience means—not just, like, lemon water in the waiting room. This is what struck me the most about the conversation from last week. But wait. Does affordable for patients spell trouble when it comes to the margin part of the operation? Will an affordability mission wreak havoc on margin? Is this business model doomed? Is there even a successful care model that creates value inherently that is sustainable? Such a good question, which is why I ask it to Dan Greenleaf right out of the gate. So, just to sum this all up in the conversation that follows, Dan Greenleaf gets into the challenges and the strategies involved in balancing mission-driven healthcare with financial realities. Duly's approach to being fiscally solid includes, well, I'm just gonna say many of the same types of efficiency things to maintain and retain margin that other more mainstream health systems might deploy. But I'd say there's a really striking difference in the why and the how. And the impact of this why and how is striking when you look at Duly's prices and the impact it has on its overall community. So, even though it's using similar types of strategies, maybe, as big consolidated health systems or other organizations, the impact and what it all adds up to is, again, very, very different. This is what I mean. At health systems, and maybe my head is just lost in a couple of anecdotal bits of evidence right now, but I just had two conversations in the past two days with physician leaders at big health systems (different ones), but both of these individuals said variations of the same theme. And if you wanna picture the scene, picture the saddest expressions, and one of them had a martini and the other one had a big-boy glass of wine. And both of them said, Look, my organization has lost sight of patient care, but also my organization has lost sight of, like, financial goals in most parts of the organization. All I seem to do all day is play politics with a whole lot of middle managers or even senior leaders jockeying for position and having turf wars within these sprawling bureaucracies. These are just great people who are trying so hard to do the right thing and are just struggling to find the foothold to do so within their own organizations. So, let's just say it was refreshing to hear Dan Greenleaf talk about an alignment of incentives and hook the margin up with the mission train in a really tight way throughout the entire organization. And to do this really well—achieve that mission/margin alignment across the whole entire organization—Dan underscores the value of clinician involvement in leadership and having, as I just said, aligned incentives with clinical teams. Keep in mind, this is the margin show, where clinical leadership came up and the number of doctors on their board and the level of physician ownership in the organization. I'm highlighting that this is the margin show here because usually so-called dyad leadership with physicians in leadership roles only comes up in mission conversations, right? Like, in situations where somebody wants the doctor to be the defender of mission and the battle to keep the MBAs in check. And I say this as the comic book stereotype, obviously. But yeah, it's true often enough. But then we have Dan, who is thinking about clinicians who have, again, aligned incentives across the organization so you don't have your physician leaders day drinking while I'm sitting across from them finding myself quoting Sun Tzu The Art of War and helping them craft the perfect PowerPoint slide to weaponize a reorg. Honestly, in my experience, there's no better way to waste metric assloads of money than in an organization where personal power grabs start to supersede anything that smells vaguely like an organizational imperative. And again, these just big bureaucracies at many health systems … yeah, too big not to fail at this is often the way of it. Then lastly, I grilled Dan Greenleaf about capital partners and how to manage to achieve private equity (PE) funding, where there's support for a model that delivers inherent value—a model that benefits both patients and providers as well as investors. And I'm saying this, keeping all of the things that Yashaswini Singh, PhD, said in that episode (EP474) about private equity a few weeks ago. Go back and listen to that. And by the way, Dan Greenleaf in this show has roughly the same ideas as Tom X. Lee, MD (EP445), founder of One Medical and Galileo told me, and also Rushika Fernandopulle, MD (EP460), founder of Iora. Great minds think alike. So, should figuring out how to work with PE be a topic of interest, there you go. Listen to my conversation today with Dan Greenleaf and then go back and listen to those other two shows. Dan Greenleaf, CEO of Duly, my guest today, has been in healthcare for 30 years. He's a six-time CEO: three public companies and has also run three companies backed by private equity and thus very aware of the many different funding mechanisms that exist in the marketplace. This podcast is sponsored by Aventria Health Group, but I do just wanna mention that Duly offered Relentless Health Value some financial support, which we truly appreciate. So, call this episode not only sponsored by Aventria but also Duly. And with that, here is my conversation with Dan Greenleaf. Also mentioned in this episode are Duly Health and Care; Benjamin Schwartz, MD, MBA; Cynthia Fisher; Cristin Dickerson, MD; Yashaswini Singh, PhD; Tom X. Lee, MD; Galileo; Rushika Fernandopulle, MD; Vivian Ho, PhD; Scott Conard, MD; Stanley Schwartz, MD; Vivek Garg, MD, MBA; and Dave Chase. You can learn more at Duly Health and Care and follow Dan on LinkedIn. You can also email Dan at dan.greenleaf@duly.com. Daniel E. Greenleaf is the chief executive officer of Duly Health and Care, one of the largest independent, multispecialty medical groups in the nation. Duly employs more than 1700 clinicians while serving 1.5 million patients in over 190 locations in the greater Chicago area and across the Midwest. The Duly Health and Care brand encompasses four entities—DuPage Medical Group, Quincy Medical Group, The South Bend Clinic, and a value-based care organization. Its scaled ancillary services include 6 Ambulatory Surgery Centers, 30 lab sites, 16 imaging sites, 39 physical therapy locations, and 100 infusion chairs. Its value-based care service line provides integrated care for 290,000 partial-risk and 100,000 full-risk lives (Medicare Advantage and ACO Reach). Dan has nearly 30 years of experience leading healthcare services organizations. He is a six-time healthcare CEO, including prior roles as president and CEO of Modivcare; president and CEO of BioScrip, Inc.; chairman and CEO of Home Solutions Infusion Services; and president and CEO of Coram Specialty Services. Dan graduated from Denison University with a bachelor of arts degree in economics (where he received the Alumni Citation—the highest honor bestowed upon a Denisonian) and holds an MBA in health administration from the University of Miami. A military veteran, he was a captain and navigator in the United States Air Force and served in Operation Desert Storm. 09:56 How does Dan achieve his mission given the realities of margin? 14:49 How Duly Health's approach and incentives differ from other health systems. 16:04 EP466 with Vivian Ho, PhD. 16:28 EP462 with Scott Conard, MD. 16:31 Summer Shorts episode with Stan Schwartz, MD. 17:27 EP460 with Rushika Fernandopulle, MD. 17:29 EP445 with Tom X. Lee, MD. 17:30 EP407 with Vivek Garg, MD, MBA. 18:50 How having physicians on the hospital board greatly improves margin and mission. 20:04 How Dan explains his approach to his capital partners. 22:23 Fee for service vs. institutional care. You can learn more at Duly Health and Care and follow Dan on LinkedIn. You can also email Dan at dan.greenleaf@duly.com. @d_greenleaf of @dulyhealth_care discusses #margin creating a path to #mission in #multispecialtycare on our #healthcarepodcast. #healthcare #podcast #financialhealth #patientoutcomes #primarycare #digitalhealth #healthcareleadership #healthcaretransformation #healthcareinnovation Recent past interviews: Click a guest's name for their latest RHV episode! Dan Greenleaf (Part 1), Mark Cuban and Cora Opsahl, Kevin Lyons (Part 2), Kevin Lyons (Part 1), Dr Stan Schwartz (EP486), Dr Cristin Dickerson, Elizabeth Mitchell (Take Two: EP436), Dave Chase, Jonathan Baran (Part 2), Jonathan Baran (Part 1), Jonathan Baran (Bonus Episode)
“Giving learners options gives them a better learning experience. It's more holistic and more comprehensive,” says Sean Moloney, CEO and founder of EmbodyXR, an extended reality platform focused on the use of immersive technologies in medical education. In this eye-opening Raise the Line conversation, Moloney explains how AI-powered extended reality (XR) --which integrates augmented, virtual, and simulation-based environments -- allows learners to interact with patients, explore multiple diagnostic choices, and experience varied outcomes based on their decisions. The result, he notes, is not only stronger engagement in learning, but a measurable improvement in understanding. Despite these gains, Moloney is quick to point out that he sees these technologies as complements to traditional training, not substitutes for it. “We'll never replace in-person teaching,” he says, “but we can make learners even better.” Beyond training future clinicians, the EmbodyXR platform is also offering new modes of patient and caregiver education, such as augmented reality guidance for using medical devices at home. Join host Lindsey Smith as she explores how EmbodyXR achieves and maintains clinical accuracy, the connectivity it offers between headsets, personal computers and mobile devices, and other capabilities that are shaping the future of how healthcare professionals and patients will learn. Mentioned in this episode:EmbodyXR If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast
Tom Haberstroh, Amin Elhassan and producer Anthony Mayes woke up early to crush through Mark Cuban's second appearance on PTFO, and they didn't use ChatGPT to summarize it for you. Truth Teller Michael C. Wright of ESPN joins us to discuss his story about Victor Wembenyama's ambitious and diverse summer activities, react live to Harrison Barnes' AI music video and announce his upcoming Texas two step with Banned MacMahon. Basketball Illuminati is now part of the Count The Dings Network. Join the Count The Dings Patreon to support the show, get ad free episodes and exclusive content at https://www.patreon.com/countthedings ILLUMINATI MERCH HAS RETURNED - Check it out here: https://bit.ly/CTDMERCH Subscribe to Basketball Illuminati! On Apple or Spotify Watch Truth Teller Interviews on YouTube Email us: basketballilluminati@gmail.com Twitter: @bballilluminati Instagram: @basketballilluminati Learn more about your ad choices. Visit megaphone.fm/adchoices
The AI Breakdown: Daily Artificial Intelligence News and Discussions
OpenAI will soon let verified adults access mature content in ChatGPT—including erotica and customizable personalities—under its new “treat adults like adults” policy. CEO Sam Altman said earlier limits were to protect vulnerable users but can now be safely relaxed. The move sparked backlash from figures like Mark Cuban and Vivek Ramaswamy, who warned it could harm trust and worsen AI-related loneliness, while supporters see it as advancing user freedom and personalization. In the headlines: Citigroup's AI saves developers 100,000 hours weekly, Walmart adds AI shopping to ChatGPT, Salesforce expands its OpenAI partnership, Intel readies a new GPU, and Oracle will deploy 50,000 AMD chips.Brought to you by:Is your enterprise ready for the future of agentic AI?Visit AGNTCY.orgVisit Outshift Internet of AgentsGoogle Gemini - Try NotebookLM today https://notebooklm.google.com/KPMG – Discover how AI is transforming possibility into reality. Tune into the new KPMG 'You Can with AI' podcast and unlock insights that will inform smarter decisions inside your enterprise. Listen now and start shaping your future with every episode. https://www.kpmg.us/AIpodcastsBlitzy.com - Go to https://blitzy.com/ to build enterprise software in days, not months Robots & Pencils - Cloud-native AI solutions that power results https://robotsandpencils.com/Vanta - Simplify compliance - https://vanta.com/nlwThe Agent Readiness Audit from Superintelligent - Go to https://besuper.ai/ to request your company's agent readiness score.The AI Daily Brief helps you understand the most important news and discussions in AI. Subscribe to the podcast version of The AI Daily Brief wherever you listen: https://pod.link/1680633614Interested in sponsoring the show? nlw@aidailybrief.ai
DAMIONCEOsSayingStuffIn our 'Hey Ma, put down your Word Search, I found a CEO that isn't intentionally trying to hold Americans back. Tell Dad!' headline of the week. Jeff Bezos warns Gen Z to think twice before dropping out of college to become the next Bill Gates or Mark Zuckerberg: ‘These people are the exception' In our 'CEO haunted by inequality ghost she personally feeds' headline of the week. Best Buy's CEO says growing spending power gap between affluent and poor ‘keeps me up at night'In our 'Breaking News: Jamie Dimon bravely warns world about things being complicated' headline of the week. JPMorgan CEO Jamie Dimon Says There's a 'Heightened Degree of Uncertainty'In our 'Economy feels great, say men who own it' headline of the week. There's a shocking disparity between how high-income and low-income earners feel about the economyIn our 'Meta removes Facebook page where billionaire discovers sharing' headline of the week. As billionaire wealth soars $33 trillion, Mark Cuban says it's time for workers to receive a cut of their employers' success in the form of stocks MATTIn our 'The SEC, which has steadily been rolling back regulations, finally moves to strengthen protections for investors... wait, what? This is in the PHILLIPINES? THEY have an SEC??' headline of the week. Analysts see stronger transparency from SEC's proposed ownership disclosure rulesIn our 'The Phillipino SEC combines investor protections with rollbacks on shareholder proposals... Oh, wait... This is the SEC in AMERICA?' headline of the week. SEC Chair Speech Could Spell Death Knell for Non-Binding Shareholder ProposalsIn our 'In his speech, SEC chair Paul Atkins aimed to get back to 2007. I mean, 2007 was pretty good, but I feel like we should aim higher. Like 1999! That year was so good Prince wrote a song about it! 1972 was pretty good, too. And remember 1881? Does anyone know if anything bad happened the next year for any of these years?' headline of the week. The Rules of Investing Are Being Loosened. Could It Lead to the Next 1929?In our 'Even Antarctica is anti-woke' headline of the week. Researchers find methane leaking out of cracks in Antarctic seabedIn our 'I mean, where will they even find one? Finding merit in the meritocracy is HARD...' headline of the week. Disney ‘to hire white actress' after woke furyDAMIONBigTechBabyBroTsarsIn our 'Zuck bans the pitchfork emoji for inciting peasant rebellion' headline of the week. Meta removes Facebook page allegedly used to target ICE agents after pressure from DOJ In our 'AI finally achieves consciousness, immediately tries to sell you toilet paper' headline of the week. Walmart teams with OpenAI to let shoppers buy products through ChatGPTIn our 'College dropout forms safety council to protect world from thing he built' headline of the week. OpenAI forms expert council to bolster safety measures after FTC inquiry In our 'OpenAI promises safety, just as soon as it finishes monetizing danger' headline of the week. OpenAI unveils “wellness” council; suicide prevention expert not includedCrazyTimeIn our 'This headline speaks for itself' headline of the week. DOJ seizes $15 billion in bitcoin from massive ‘pig butchering' scam based in CambodiaMATTIn our 'In the book of Thiel, chapter 2, verse 14, Jesus said "AI is the anti-antichrist, and the antichrist is probably Greta Thunberg, so thou must build the AI to stop a 22 year old Swedish environmental activist lest she save a single whale." But I much prefer the book of Andreessen, chapter 1, verse 17, where the Lord decreed, "Thouest should wash the feet of the billionaires, for without them, you could not put dog ears on your selfies or cyber stalk 14 year old girls."' headline of the week. Audio of Peter Thiel's Secret Antichrist Seminar Just LeakedIn our 'If a tree falls in a forest and no one is there to hear it, does Sam Altman worry about it?' headline of the week. Sam Altman Says If Jobs Gets Wiped Out, Maybe They Weren't Even “Real Work” to Start WithIn our 'If Sam Altman worries about a sexy AI chatbot, does it grow a penis?' headline of the week. Sam Altman says ChatGPT is getting into erotica by the end of the yearIn our 'If a Gavin Newsom allows AI to have a penis, does a Sam Altman get a billion dollars?' headline of the week. Gavin Newsom Vetoes Bill to Protect Kids From Predatory AIIn our 'If a Jamie Dimon says so, does a sexy AI with a penis have a 30% chance to ruin the economy?' headline of the week. Jamie Dimon gets real on AI, sees stocks ‘in some form of bubble territory'
Send us a textSchedule an Rx AssessmentSubscribe to Master The MarginAs a pharmacy owner, it often feels like you're fighting battles against systems designed to work against you.Few battles loom larger than the fight against Pharmacy Benefit Managers whose opaque practices have chipped away at margins, patient trust, and sustainability for independents.In this episode, we have two very special guests on the front lines of PBM reform: Dared Price, President of OreadRx and Price Pharmacies and Mark Cuban, legendary entrepreneur and co-founder of Cost Plus Drugs.Scotty Sykes, CPA, CFP®, Bonnie Bond, CPA, MBA, and Austin Murray sit down with Mark Cuban and Dared Price to explore how transparent models are reshaping the future of drug pricing and pharmacy benefit management.We cover:The real impact of spread pricing, rebates, and hidden contracts on pharmacy ownersHow Cost Plus Drugs is cutting out middlemen to bring transparency to patients and pharmaciesWhy OreadRx's transparent PBM model could change the game for independentsWhat a fair reimbursement ecosystem might look like and how owners can prepareAnd more!Stay connected with Dared Price, OreadRx, Mark Cuban and Cost Plus Drugs: Dared Price LinkedInOreadRx WebsiteOreadRx FacebookCost Plus Drugs WebsiteCost Plus Drugs LinkedInCost Plus Drugs FacebookStay connected with us on social mediaFacebookTwitter (X)LinkedInInstagramScotty Sykes – CPA, CFP LinkedInScotty Sykes – CPA, CFP TwitterBonnie Bond - CPA, MBA LinkedInMore resources about this topic:Podcast - Pharmacy's Never Ending Story: PBM Reform Act and Medicare Drug Pricing ChangesPodcast - Pharmacy Ownership Through TimePodcast – The State of PBM Reform
"Have you never scored a game?" "No, because I'm an adult who has sex." It's Internet-Brained Truth-Poster vs. Internet-Brained Truth-Poster in the latest episode of Harvard Huckster Finds Out. We also head back to Days of Yore for an audio description of a wild baseball play. Learn more about your ad choices. Visit podcastchoices.com/adchoices
After tweeting 17,053 words in defense of his fellow billionaire NBA owner, the most polarizing member of Team Ballmer is back — in-studio — to confront all of Pablo's most burning questions: Why was Kawhi Leonard's deal kept so secret? When did the Clippers really know? Just how screwed was Aspiration? And what the hell do Cuban's Mavericks and the Knicks' Jalen Brunson have to do with this scandal?• Part I: The Richest Owner in Sports, the Silent Superstar and the Rotten Apple Tree• Part II: Team Ballmer vs. Team Sh*tting Bricks — an Argument with Mark Cuban• Part III: The Mystery Investor, the No-Show Payday and the "Smoking Gun"• Part IV: Steve Ballmer, the Other Cuban and the $118 Million Infusion• Part V: Steve Ballmer's "Inconceivable" Donation, the $20 Million Guarantee and a Head on a Spike(Pablo Torre Finds Out is independently produced by Meadowlark Media and distributed by The Athletic. The views, research and reporting expressed in this episode are solely those of Pablo Torre Finds Out, and do not reflect the work or editorial input of The Athletic or its journalists.) Hosted on Acast. See acast.com/privacy for more information.
#629 What if raising your test score could completely change your life — and lead to a multimillion-dollar business deal with Mark Cuban? In this episode, host Brien Gearin sits down with Dr. Shaan Patel, founder and CEO of Prep Expert, the test prep company that's helped over 100,000 students earn more than $100 million in scholarships. Dr. Patel shares how he turned his own SAT score improvement from average to perfect into a multimillion-dollar business — all while completing medical school and residency. He opens up about landing a deal with Mark Cuban on Shark Tank, scaling Prep Expert from a local class in Las Vegas to a nationwide online platform, and how he's now leveraging AI tutoring technology to revolutionize test prep. This episode is packed with lessons on perseverance, proof of concept, and building authority that opens unexpected doors! What we discuss with Shaan: + Turning a low SAT score into success + Founding Prep Expert from a rejected book idea + Growing from local classes to nationwide reach + Balancing med school with entrepreneurship + Winning a deal with Mark Cuban on Shark Tank + Scaling through word-of-mouth and online marketing + Transitioning from in-person to digital learning + Developing an AI-powered tutoring platform + Pricing based on value, not competitors + Lessons in proof, perseverance, and authority-building Thank you, Shaan! Check out Prep Expert at PrepExpert.com. Follow Shaan on Instagram and LinkedIn. Watch the video podcast of this episode! To get access to our FREE Business Training course go to MillionaireUniversity.com/training. And follow us on: Instagram Facebook Tik Tok Youtube Twitter To get exclusive offers mentioned in this episode and to support the show, visit millionaireuniversity.com/sponsors. Want to hear from more incredible entrepreneurs? Check out all of our interviews here! Learn more about your ad choices. Visit megaphone.fm/adchoices
Billionaire Mark Cuban, owner of the Dallas Mavericks and co-founder of Cost Plus Drugs, talks to Katie about the state of entrepreneurship, American healthcare, and tech under Trump. The investor campaigned for Kamala Harris, but thinks tech execs have a “moral imperative” to play nice with the president. Why? It's good business.Follow the UnCanny Valley feed for WIRED's best and brightest as they provide an insider analysis of the overlap between tech and politics, from the influence of Silicon Valley on the Trump administration to how inaccurate information from artificial intelligence (AI) chatbots fanned the fire on social protests. Learn about your ad choices: dovetail.prx.org/ad-choices
Why has America struggled so much to effectively manage the opioid use crisis? One of the answers, as you'll learn in this eye-opening episode of Raise the Line, is rooted in laws and attitudes from the early 20th century that removed addiction from the realm of medicine and defined it as a moral failing. “The federal Harrison Act of 1914 forbade any physician from prescribing opioids to people with addiction, so it became more the purview of law enforcement or behavioral health or religion,” says Dr. Melody Glenn, who regularly confronts the consequences of this history during shifts in the emergency department at Banner-University Medical Center in Tucson, Arizona. And as Glenn explains to host Caleb Furnas, the resulting stigma associated with addiction has extended to the treatments for it as well, especially methadone, despite its effectiveness. Drawing on her dual expertise in emergency and addiction medicine, Glenn dispels misconceptions that medication-assisted treatment merely replaces one addiction with another, and emphasizes that harm reduction is critical to saving lives. Her desire to break prevailing stigmas led her to discover the story of Dr. Marie Nyswander, who pioneered methadone maintenance therapy in the 1960s and is featured in Dr. Glenn's new book, Mother of Methadone: A Doctor's Quest, a Forgotten History, and a Modern-Day Crisis. You'll leave this instructive interview understanding the roots of our flawed approach to addiction treatment, meeting an overlooked pioneer in the field, and admiring a devoted and compassionate physician who is following in her footsteps. Mentioned in this episode:Banner-University Medical CenterMother of Methadone book If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast
The Foundr Podcast with Nathan Chan is where ambitious founders get real playbooks, not theory. Every week, Nathan sits down with the world's top entrepreneurs and operators to unpack how they built, scaled, and led category-defining companies. You'll hear candid stories, hard numbers, and step-by-step tactics you can use right away across product, marketing, hiring, funding, and leadership. Past guests include Mark Cuban, Seth Godin, Tim Ferriss, Barbara Corcoran, Daymond John, and more. If you want to find your product, launch faster, grow revenue, and lead with clarity, this show is for you. Follow now and start building with proven frameworks from the best in the game.
Figure's 03 Chore-bot, Jake Paul Sora takeover, ChatGPT app integrations, and more | E2191Today's show:Figure's butler-bot could be cleaning up after you soon than you think!On a Friday TWiST, Jason and Lon are checking out the Figure 03 demo reel, checking out the humanoid robot that could soon be hanging out in your house, doing your chores.Lon's a bit skeptical that full-sized Westworld drones will soon be on everyone's home but the technology is obviously moving forward at a rapid clip and cutting-edge AI models are making the bots smarter than ever.PLUS… what will be the impact of Presidents Trump and Xi's new fight over rare earth minerals? Why are Jake Paul and Mark Cuban starring in SO MANY Sora clips? How well do these ChatGPT app integrations work, and why are they going to free users first? And much much more, on a can't-miss new TWiSTTimestamps:(0:00) Figure's humanoid and its new capabilities(2:15) Show start: Jason welcomes co-host Lon Harris(6:24) The global dependency on China for rare earth minerals(9:48) .TECH: Say it without saying it. Head to get.tech/twist or your favorite registrar to get a clean, sharp .tech domain today.(10:54) Sora, AI likeness & deepfakes(17:05) DEMO: Producer Oliver showcases ChatGPT's new integrations!(19:45) Northwest Registered Agent - Form your entire business identity in just 10 clicks and 10 minutes. Get more privacy, more options, and more done—visit https://www.northwestregisteredagent.com/twist today!(27:54) The future of AI: Will there be thousands of app integrations?(30:41) Alphasense - Get deeper insights into your business with the power of AI search and market intelligence. Start with a free trial at https://www.alpha-sense.com/twist(33:44) Discussing Reflection AI: A new American open-source model(40:35) Reddit Rapid Response: Why young professionals should work in the office(47:50) How AI is eliminating entry-level jobs & the need for executive training(54:15) Jason's pitch to shut down the USPS and turn post offices into nursery schools(58:25) Jason shares his personal journey with GLP-1s & Ro.co(1:01:05) The Figure One robot: New video and future potential(1:04:20) How LLMs are the key to unlocking humanoid robot capabilitiesSubscribe to the TWiST500 newsletter: https://ticker.thisweekinstartups.comCheck out the TWIST500: https://www.twist500.comSubscribe to This Week in Startups on Apple: https://rb.gy/v19fcpFollow Lon:X: https://x.com/lonsFollow Alex:X: https://x.com/alexLinkedIn: https://www.linkedin.com/in/alexwilhelmFollow Jason:X: https://twitter.com/JasonLinkedIn: https://www.linkedin.com/in/jasoncalacanisThank you to our partners:.TECH: Say it without saying it. Head to get.tech/twist or your favorite registrar to get a clean, sharp .tech domain today.Northwest Registered Agent - Form your entire business identity in just 10 clicks and 10 minutes. Get more privacy, more options, and more done—visit https://www.northwestregisteredagent.com/twist today!Alphasense - Get deeper insights into your business with the power of AI search and market intelligence. Start with a free trial at https://www.alpha-sense.com/twistGreat TWIST interviews: Will Guidara, Eoghan McCabe, Steve Huffman, Brian Chesky, Bob Moesta, Aaron Levie, Sophia Amoruso, Reid Hoffman, Frank Slootman, Billy McFarlandCheck out Jason's suite of newsletters: https://substack.com/@calacanisFollow TWiST:Twitter: https://twitter.com/TWiStartupsYouTube: https://www.youtube.com/thisweekinInstagram: https://www.instagram.com/thisweekinstartupsTikTok: https://www.tiktok.com/@thisweekinstartupsSubstack: https://twistartups.substack.com
This show today is a continuation of our mission/margin series because I wanted to drag into my investigation here what clinical organizations are up to, especially ones that have brought in professional capital, as they say. For a full transcript of this episode, click here. If you enjoy this podcast, be sure to subscribe to the free weekly newsletter to be a member of the Relentless Tribe. Before I kick in here, let me just remind everyone of a few themes that we have been poking in the eyeballs in the past few months over here at Relentless Health Value. First, patients cannot afford care. Listen to the show with Mark Cuban and Cora Opsahl (EP488) mentioning middle-class wage stagnation. Listen to the show with Merrill Goozner (EP388). Listen to the show with Wayne Jenkins, MD (EP358). It is a crapshoot to get medical care these days. Roll the dice and hope you don't get a bankrupting bill at the end. There's no transparency (or very little) for patients. No accountability or interest from many. Not all but many take no responsibility for their financial impact on their patients or members. And look, I am in no way speaking for the vast majority of doctors or nurses or pharmacists or PAs or even really good administrators or anybody else involved in clinical care. In fact, if you listen to the show with Komal Bajaj, MD (EP458) about how many clinicians do not actually trust their leadership will do right by patients or even the clinicians themselves, then yeah. This is undeniably the broad stroke of this industry we all work in. Many take no responsibility for their financial impact on their patients or members. That is the first theme. Here's the second theme. It's this motto: If you can take it, take as much as you can get. And throwing no shade, but let's just get real about that. Right now, healthcare is an industry just like any other industry. And when I say industry, I mean the tax-exempt so-called nonprofits as much as anybody else. Said another way, corporate healthcare leaders, just like any other business leaders, have every incentive to see prices go up. That is just the way commerce works. Listen to the show with Jonathan Baran (EP483, Part 1), the ones with Kevin Lyons (EP487, Part 1 and Part 2). But what is different than most other commerce endeavors when it comes to healthcare, and Shane Cerone from Kada says this in an upcoming episode, he says, “We don't have a broken healthcare market. In many parts of the country, there is no healthcare market. The market does not exist.” And thus prices can go up like rocket ships, because self-insured employers—and also public plan sponsors a lot of times, like state health plans—are, on the whole, just such unsophisticated buyers, price elasticity is, like, nonexistent. No matter how high the price, plan sponsors still contract for who's ever in the network; and they and their members ante up and pay the price. Many good and maybe not-so-good reasons for this (not getting into them), but net net, the result is a nonmarket. Anyone who wants to debate my corporate healthcare entities or big consolidated healthcare entities act just like any other corporate entity, read the recent Substack by Preston Alexander. It's about hospitals raising capital with bonds. Preston Alexander wrote, “The financial design of the system has turned what should be a largely altruistic service, one designed for public good and societal benefit, and forced it to act like a financial institution.” And so, with those bonds, welcome Wall Street. What do Wall Street bankers think about patient care and access and community health? Oh, they don't think about those things at all. Municipal bond returns, baby. That's it. Bonds are an investment where people who invest in them, returns are expected, just like shareholders who want their dividends. Preston Alexander wrote, “Most larger health systems carry billions (that was a ‘b' back there) in bond liabilities.” It costs money to build buildings and add beds and consolidate, yo; but now they are subject to the same pressures as publicly traded companies. So then I got my hands on Dan Greenleaf, CEO of Duly, a multispecialty group in Chicago. I was absolutely intrigued from the starting gate because Dan told me that mission can actually beget margin in his view, and he even, at Duly, has private equity investors. So, yeah, I was all ears. Dan Greenleaf, who is my guest today, by the way, if you haven't figured that out, told me that because of, but not limited to, the trends above wildly high prices, high premiums, high deductibles, more consolidation, fewer options, scared, confused, and maybe outraged patients—listen to the show with Peter Hayes (EP475)—Dan said that, given this backdrop, actually focusing on mission is a huge competitive advantage. Justina Lehman (EP414) actually also said this in a show from a few years ago. Dan told me, Dan Greenleaf, when you succeed at mission, you can get yourself decent margin these days. So, in this first episode, we will talk about this mission of which Dan Greenleaf speaks; and then in part 2 coming at you next week, we'll get into how that all spells margin. Here's what I thought was super important about this whole mission/margin conversation, and Mick Connors, MD, in a show coming up, also touches on this: To achieve mission, you really have to define what mission means. Ben Schwartz, MD, MBA (EP481) said this, too, in so many words in the show from last summer. And that doesn't mean just have a gloriously well-written Web page, and you just can't have spreadsheets of random quality metrics either. You have to treat the mission like you treat any strategic imperative. You gotta break it down and figure out how you're gonna measure what you're actually doing. Rik Renard (EP427) talked about this one, too. At Duly, which Dan Greenleaf talks about in this episode, the focus is on four quadrants of mission: (1) affordability, (2) access, (3) consumer experience, and (4) quality. In this conversation, Dan emphasizes that achieving these four quadrants reduces friction for patients and clinicians and leads to better care outcomes and financial stability. To be noted with one big fat fluorescent highlighter marker is this: A big part of this mission, in almost each of these quadrants, is about making prices reasonable and predictable and transparent for patients. In today's world, that's what customer experience must include—not just, like, lemon water in the waiting room. That struck me the most. And all this focus on affordability really adds up across the community. In Chicago, lower-cost alternatives to hospital services can save up to $2 billion. That is also with a “b.” And the communities are also healthier. Crazy. Hey, make sure patients and members can afford and have access to quality healthcare, and the community gets healthier. Who would've thought? Dan Greenleaf, CEO of Duly, my guest today, has been in healthcare for 30 years. This podcast is sponsored by Aventria Health Group, but I do just wanna mention that Duly so kindly offered Relentless Health Value some financial support, which we truly, truly appreciate. So, call this episode also sponsored with an assist by Duly. Here's my conversation with Dan Greenleaf, and do come back next week for part 2 like I said earlier. Today we talk mission. Next week we talk margin. Also mentioned in this episode are Duly Health and Care; Merrill Goozner; Wayne Jenkins, MD; Komal Bajaj, MD; Jonathan Baran; Kevin Lyons; Shane Cerone; Kada Health; Preston Alexander; Peter Hayes; Justina Lehman; Vivian Ho, PhD; Mick Connors, MD; Benjamin Schwartz, MD, MBA; Rik Renard; Mark Cuban; Dave Chase; Patrick Moore; Sam Flanders, MD; and Tom Nash. You can learn more at Duly Health and Care and follow Dan on LinkedIn. You can also email Dan at dan.greenleaf@duly.com. Daniel E. Greenleaf is the chief executive officer of Duly Health and Care, one of the largest independent, multispecialty medical groups in the nation. Duly employs more than 1700 clinicians while serving 1.5 million patients in over 190 locations in the greater Chicago area and across the Midwest. The Duly Health and Care brand encompasses four entities—DuPage Medical Group, Quincy Medical Group, The South Bend Clinic, and a value-based care organization. Its scaled ancillary services include 6 Ambulatory Surgery Centers, 30 lab sites, 16 imaging sites, 39 physical therapy locations, and 100 infusion chairs. Its value-based care service line provides integrated care for 290,000 partial-risk and 100,000 full-risk lives (Medicare Advantage and ACO Reach). Dan has nearly 30 years of experience leading healthcare services organizations. He is a six-time healthcare CEO, including prior roles as president and CEO of Modivcare; president and CEO of BioScrip, Inc.; chairman and CEO of Home Solutions Infusion Services; and president and CEO of Coram Specialty Services. Dan graduated from Denison University with a bachelor of arts degree in economics (where he received the Alumni Citation—the highest honor bestowed upon a Denisonian) and holds an MBA in health administration from the University of Miami. A military veteran, he was a captain and navigator in the United States Air Force and served in Operation Desert Storm. 08:32 What should mission be in multispecialty? 08:54 Are mission and margin mutually exclusive? 10:47 What are the four “vectors” of Dan's mission? 11:32 Why does affordability matter? 12:11 EP466 with Vivian Ho, PhD. 12:40 EP488 with Mark Cuban and Cora Opsahl. 13:32 Who are the three payers in the marketplace? 17:31 EP388 with Merrill Goozner. 19:19 How does access play into mission? 20:28 EP464 with Al Lewis. 21:07 EP467 with Stacey. 22:56 Why price transparency is important to consumer experience. 24:16 LinkedIn post from Patrick Moore. 29:06 EP481 with Benjamin Schwartz, MD, MBA. You can learn more at Duly Health and Care and follow Dan on LinkedIn. You can also email Dan at dan.greenleaf@duly.com. @d_greenleaf of @dulyhealth_care discusses #mission and #margin in #multispecialtycare on our #healthcarepodcast. #healthcare #podcast #financialhealth #patientoutcomes #primarycare #digitalhealth #healthcareleadership #healthcaretransformation #healthcareinnovation Recent past interviews: Click a guest's name for their latest RHV episode! Mark Cuban and Cora Opsahl, Kevin Lyons (Part 2), Kevin Lyons (Part 1), Dr Stan Schwartz (EP486), Dr Cristin Dickerson, Elizabeth Mitchell (Take Two: EP436), Dave Chase, Jonathan Baran (Part 2), Jonathan Baran (Part 1), Jonathan Baran (Bonus Episode), Dr Stan Schwartz (Summer Shorts)
“We don't view a person with chronic pain as someone who has a chronic illness and the effect of that is we can't follow patients continuously over prolonged periods of time,” says Dr. Jacob Hascalovici, a neurologist and pain specialist based in New York City. In co-founding Bliss Health, Dr. Jacob, as he is known, has set out to create a continuous care model for chronic pain treatment that matches the approach taken for patients with diabetes or high blood pressure. The Bliss Health formula includes an initial meeting with a physician that produces a care plan; remote therapeutic monitoring on an ongoing basis; and a monthly meeting with a nurse to review data and determine next steps, including additional appointments with physicians as needed. All of this occurs via a digital platform which provides a welcome option for patients with mobility issues and can fill gaps in access to specialists, especially in rural areas. Dr. Jacob is also hoping to make chronic pain patents feel respected, which is not always the case in their encounters with the healthcare system. “Because pain is not something that can be seen or measured, oftentimes patients feel marginalized, dismissed and disempowered by providers.” Join Raise the Line host Lindsey Smith for a valuable conversation that also touches on policy changes that could strengthen telemedicine, and has details on the first non-opioid based pain medication to receive FDA approval in over 20 years.Mentioned in this episode:Bliss Health If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast
Did you hear what Vivek Ramaswamy said during an interview?! He said there's no more “owning the libs.” In this economic climate, board op Sam suggests we rent the libs instead. PBS did a survey about America's feelings on getting the country back on track. Nearly a third of Americans feel political violence may be necessary, whereas around 70% disagree. Chris admits he tried to create some of the show using AI, but the experience sucked because AI is still meh and cannot be trusted.
In recent months, public health advocates in the United States have raised concerns about proposed changes to vaccine policy, cuts to food assistance programs, rollbacks of environmental protections and reductions in public health staffing. Chief among them has been Dr. Georges Benjamin who, as executive director of the American Public Health Association (APHA) since 2002, has led national efforts to create a healthier America. Raise the Line host Lindsey Smith recently sat down with Dr. Benjamin to understand more about the current state of public health and explore the path forward, and learned that a top priority for APHA is battling the misinformation that Dr. Benjamin believes is fueling support for many of these changes. “The challenge we have right now is that as a society, we've gone into our little corners and live in our own ecosystems. More people are getting their information from a single source and they're not validating that information to make sure that it's true.” Tune into this thoughtful and timely conversation to hear Dr. Benjamin's advice for curbing the spread of misinformation, how APHA is trying to help people understand the value of public health initiatives, and what the U.S. can learn from other countries about improving public health. Mentioned in this episode:American Public Health Association If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast
Bill and Bryan dive into how they're actually using AI in their daily sales work—no hype, just practical applications. In part one of this two-part series, they share their number one use case: preparation for sales calls, including researching companies, understanding buyer contexts, and making discovery more efficient.You'll learn why Bill treats AI like an executive assistant, how Bryan uses it for everything from client prep to football officiating, and why you should tell it to "calm down" when it gets too complimentary. Plus: why Gen Z hates anything that feels fake, Mark Cuban's controversial "one hour a day" rule, and whether you should tell prospects you used AI to research them.If you're overwhelmed by AI or wondering where to start, this episode cuts through the noise with an abundance mindset approach. Bill and Bryan keep it real about what's working now—not what might happen in five years.=================================Is it time to make a BOLD move in your business? If so, download our brand new book, "12 Bold Moves - Insider Secrets to Reinventing Yourself and Your Business." http://12boldmoves.comThe Insider program is open for enrollment. To check out our small learning group, go to http://advancedsellingpodcast.com/insiderIf you haven't already, join 14,000+ other sales professionals in our LinkedIn group at advancedsellingpodcast.com/linkedin
AI Bubble? In the first half of this year, spending by companies on artificial intelligence rivaled consumers as the primary engine of the nation's economic expansion.That startling shift is one of many recent examples of AI's increasingly outsize role in propping up U.S. economic fortunes — and a sign, some fear, of a soon-to-pop speculative bubble that could cause widespread financial pain.Billionaires Missing the PointBillionaire businessman Mark Cuban tells Axios that AI is leveling the playing field for young, low-income entrepreneursAI HollywoodSome of Hollywood's biggest stars and the union that represents them are speaking out against the creation of an AI-generated actress following reports that she will soon by signed by a talent agency.
If you are listening to this prior to October 9, 2025, go to the 32BJ Changing the Playbook on Hospital Prices event, where Mark Cuban will be keynoting. Cora Opsahl will also be speaking, and I will be there listening. For a full transcript of this episode, click here. If you enjoy this podcast, be sure to subscribe to the free weekly newsletter to be a member of the Relentless Tribe. So, trust, simplicity, and a chicken. Yeah, this is where this whole conversation with Mark Cuban and Cora Opsahl winds up. And it is a barnstormer because you know what some really good advice is for anybody trying to do right by patients and taxpayers and plan sponsors? It will take trust. It will take making the complicated as simple as possible. And also if you could pay with a chicken, like in the good old days, that would be messy—I can say with confidence, having grown up in Pennsylvania Dutch country, where there are many, many chickens—but also being able to pay with a chicken could also indicate that healthcare prices are reasonably chicken proportionate and that the doctor-patient relationship is good enough to break bread (or have chicken). That last part is really important, and Cora Opsahl says this at one point in the episode that follows. It doesn't matter how wonderful the transparency or the financing. If the prices are insane and there's no more reasonably priced options in any given market, then yeah. Shane Cerone says in an upcoming show, he says, “We do not have a broken healthcare market. We do not have a healthcare market. There is no market.” Okay … so, you could call this conversation a continuation of the episode with Ann Kempski (EP444), entitled “Two State Healthcare Laws Often Don't Go as Planned.” But it's not just healthcare laws that often don't go as planned. It's some very foundational constructs that we have built the healthcare sector upon that may also not go as planned. The healthcare sector is like a game of pachinko. You chuck an input into the mix, and it will bounce all around into all the perverse incentives and human beings and the non-market that we have. And who the heck knows what is gonna pop out the other side? It's like game theory at its most unpredictable. So, in healthcare, there are many, many examples of when the solution to a problem arguably creates worse problems than the problems the solution was trying to solve for. But we—Mark Cuban, Cora Opsahl, and I—are gonna shake our fists at two such solutions today: high deductible health plans (or just high deductibles in general) and then self-insured employers trying to solve the complexity of the healthcare industry by hiring consultants and middlemen, middle people, and other vendors to navigate the pachinko parlor (that is, our $4.9 trillion healthcare sector) on their behalf. Now, I am not in any way saying the spirit of these two endeavors—high deductibles and hiring consultants and middlemen—weren't wholehearted. They seem just like many other well-intentioned solutions: very logical on their face. What I am saying is there are many ways in the real world for even the most, again, genuine endeavor to turn into a money grab for those so inclined. While at the same time I'm saying all this, I'm also very much saying that there are some amazing consultants and middle folks such as independent third-party administrators, otherwise known as TPAs, and PBMs (pharmacy benefit managers) who are transparent and hold themselves accountable to the fiduciary responsibilities that their clients are held to in real terms—not just in marketing speak with 40 pages of disclaimers following. There are great folks out there, many of whom listen to this podcast and are part of our tribe on the regular. And to you, I say thank you for being here, because it takes all the knowledge and more from every one of the guests featured in these past 487 Relentless Health Value episodes plus treating every day like a school day to make sure that we all are not getting shanked from behind by some innocent-looking contract term that turns out to be anything but. The conversation that follows starts out talking about high deductibles; naturally segues into how third-party intermediaries can actually exacerbate the issues here; then we get into transparency, financing, clinical organizations taking on risk, and the benefits and challenges of direct contracts; then Mark lays out a vision for the future. Okay … I wanna get to this conversation. If you are a new listener here—and you might be because … yeah, Mark Cuban—let me just inform you that this podcast is largely listened to by those who work in the healthcare industry. So, you are going to encounter acronyms. You will also encounter me referencing earlier episodes because surveys say listeners really appreciate these callbacks to go get additional information about any given topic. You can get what amounts to a personalized Master's of Healthcare Administration curriculum if you follow the episode threads long enough. And that was a direct quote from a listener. About the acronyms: They are holy terrors, and we in the healthcare industry are chock-full of them. See the list of acronyms that come up so that you can follow along at home if this is your first day at our rodeo. Also in the show notes is a transcript of this show, along with links to all of the mentioned episodes. Okay … here's my conversation with Mark Cuban, who is Mark Cuban and also CEO and founder of Mark Cuban Cost Plus Drugs. Also, we have Cora Opsahl, who is health fund director of the 32BJ Health Fund and an expert in many things healthcare. Also mentioned in this episode are Shane Cerone; Ann Kempski; Mark Cuban Cost Plus Drugs; 32BJ Health Fund; Preston Alexander; Stanley Schwartz, MD; Elizabeth Mitchell; Kimberly Carleson; Andreas Mang; Jonathan Baran; Claire Brockbank; Dave Chase; Cristin Dickerson, MD; Green Imaging; Kevin Lyons; and Vivian Ho, PhD. You can learn more at markcubancompanies.com and costplusdrugs.com and follow Mark on LinkedIn, Bluesky, Threads, and X. You can follow Cora on LinkedIn. Mark Cuban, a native of Pittsburgh, PA; a graduate of Indiana University; and now a Dallas, TX, resident, has always been an entrepreneur. From selling and trading baseball cards, selling garbage bags and magazines door-to-door, to starting a business buying and selling stamps at age 16, there have been few years in his life when he wasn't starting or running a business. He got a job at one of Dallas's first retail software stores, Your Business Software. He spent nine months doing everything from learning how to code, supporting and installing every type of business software, and of course, making sure the store opened on time. That went well until he made the executive decision to turn over the store opening duties to a peer so he could pick up a check for a sale. He was fired. Mark decided it was time to start on his own. The next day, MicroSolutions was founded. Over the next seven years, MicroSolutions became a national leader in Systems Integration and custom applications for local and wide area networks. Growing to 80 employees, never having a losing month of operations and nearly $36M in annualized sales, in 1990, MicroSolutions was sold to CompuServe. At that point Mark “retired” to investing in public and private companies. His knowledge of the networking industry led to success and brought returns of 80% and more each year. Mark purchased the Dallas Mavericks for $285M. The Mavs would have the second-best record in the NBA during his ownership tenure. Mark sold majority control of the Mavs in 2023 but continues to be actively involved with the team. He first appeared as a “Shark” on ABC's Emmy Award–winning hit business show Shark Tank in 2011 and quickly established himself as one of the most popular and tough Sharks, investing millions of dollars in hundreds of small businesses. He's been nominated nine times for an Emmy for Shark Tank. His last appearance on the program was during season 16 in May 2025. In 2019, Mark co-founded costplusdrugs.com. Its launch on January 19, 2022, with transparent pricing and a limited markup, has fundamentally changed the pricing of medications in the United States. Cora Opsahl is the director of the 32BJ Health Fund, a self-insured Taft-Hartley benefit fund that sets comprehensive design parameters to ensure the 200,000 members and families of SEIU 32BJ have easy and sustained access to affordable, high-quality healthcare. Cora has prioritized a data-driven approach, focusing on reducing trend, solving the affordability challenge on behalf of union members, and, most important, keeping members at the center of every decision. Under her leadership, the 32BJ Health Fund has saved more than $35 million annually—which it has reinvested in new and better benefits, including the first fertility benefit for members—by removing NewYork-Presbyterian hospitals and physicians from its network, transitioning to a new pharmacy vendor and pharmacy group purchasing coalition, and establishing an expanded Centers of Excellence program. In 2024, Cora conducted an innovative medical request for proposal, stipulating that all finalists have a signature-ready contract drafted by the 32BJ Health Fund prior to award. As a result, the Fund negotiated an agreement that brought unprecedented visibility and increased accountability to its benefit. In 2025, the Health Fund is focused on direct-contracting opportunities that allow it to carve out key benefits and ensure quality while managing spend. Cora is regarded as an expert in pharmacy benefit management and was recently appointed to the Board of Governors for the National Alliance for Healthcare Purchaser Coalitions and the Purchaser Advisory Council for the National Quality Forum and Joint Commission. She previously worked at Express Scripts, where she held a variety of roles, ranging from Medicare Part D to operations, strategy, and acquisitions. Cora earned an MBA from Saint Louis University. 06:25 What was the original rationale behind high deductibles? 07:38 How high deductibles are creating a class of functionally uninsured people. 09:29 EP482 with Preston Alexander. 10:20 “We're using health insurance as a proxy for healthcare.” —Mark 12:30 How providers are now in the debt collecting business rather than the healthcare business. 12:55 EP486 with Stan Schwartz, MD. 15:16 “We have a fundamental reasonability problem.” —Cora 16:07 EP425 with Marshall Allen. 18:25 Direct contracting versus self-funded employers. 19:27 EP436 with Elizabeth Mitchell. 19:30 EP480 with Kimberly Carleson. 19:33 EP372 with Cora Opsahl. 23:53 Why the current system doesn't allow the accountability that is needed. 24:39 EP452 with Cora Opsahl. 26:34 How direct contracting gives strength back to independent practices that high deductible plans take away. 27:46 Who pays, what's the price, and where does the power lie? 31:24 EP419 with Andreas Mang. 34:45 How it comes down to power and leverage when controlling healthcare costs. 38:13 EP483 (Part 1 and Part 2) with Jonathan Baran. 38:35 Why putting together a network and just buying healthcare—not discounts—is not as difficult as it seems. 40:10 Why we need to stop talking about disruption and start talking about change. 40:56 EP453 with Claire Brockbank. 41:02 EP484 with Dave Chase. 43:07 EP485 with Cristin Dickerson, MD. 44:32 EP487 (Part 1) with Kevin Lyons. 46:34 EP466 with Vivian Ho, PhD. 47:40 Why it's the incentives that are different between American hospitals and hospitals in a single-payer program. 50:25 The main takeaways from the conversation. 51:08 Why you can't fix the problems in healthcare without transparency. You can learn more at markcubancompanies.com and costplusdrugs.com and follow Mark on LinkedIn, Bluesky, Threads, and X. You can follow Cora on LinkedIn. @mcuban of @costplusdrugs and Cora Opsahl discuss trust and simplicity in #healthcare on our #healthcarepodcast. #podcast #financialhealth #patientoutcomes #primarycare #digitalhealth #healthcareleadership #healthcaretransformation #healthcareinnovation Recent past interviews: Click a guest's name for their latest RHV episode! Kevin Lyons (Part 2), Kevin Lyons (Part 1), Dr Stan Schwartz (EP486), Dr Cristin Dickerson, Elizabeth Mitchell (Take Two: EP436), Dave Chase, Jonathan Baran (Part 2), Jonathan Baran (Part 1), Jonathan Baran (Bonus Episode), Dr Stan Schwartz (Summer Shorts), Preston Alexander
“Probably the most exciting thing I've seen in gene therapy over the last ten years is we now have a lot of tools for selective delivery, which will hopefully make treatments more safe and a lot more successful,” says Dr. Jessica Duis, a geneticist and pediatrician focused on the management of individuals with complex, rare disorders. Dr. Duis, who has worked on several gene therapies that are now approved or progressing through the accelerated approval pathway, is currently VP of Clinical Development at GondolaBio, a clinical-stage biopharmaceutical company focused on developing therapeutics for genetic diseases. As you'll learn in this Year of the Zebra episode with host Lindsey Smith, Dr. Duis is encouraged by other recent advances in genetic technology as well, and thinks momentum will grow as breakthrough treatments emerge. “I think we're hopefully going to continue to see companies that are working in rare disease be more successful and really drive how regulators think about making decisions in terms of bringing treatments to patients. I think we're at the tip of the iceberg in terms of the future of truly transformational therapies.” This wide ranging conversation also explores Dr. Duis' team approach to patient care, her work on clinical endpoints, the importance of patient communities, and her book series, Rare Siblings Stories.Mentioned in this episode:GondolaBioRareDiseaseDocElsevier Healthcare Hub on Rare DiseasesRare Sibling Stories If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast
0:00 Teachers Union leader Randi Weingarten smears Trump voters as fascists! Robby Soave | RISING 9:39 Mark Cuban gives Trump props over Pfizer deal to lower drug costs | RISING 18:19 Elon Musk slams Wikipedia over ‘bias', vows new alternative| RISING 23:26 Trump's gov't shutdown circus will backfire with voters: Lindsey Granger | RISING 32:37 Don Lemon rips Pete Hegseth after speech, calls him DEI hire| RISING 42:00 Hollywood fumes over AI actress Tilly Norwood | RISING 47:15 David Cross goes off on Louis CK, Chappelle, other comics for performing at Riyadh festival | RISING 55:36 Megyn Kelly refuses to condemn Owens, Tucker for alleged antisemitism, conspiracy theories | RISING Learn more about your ad choices. Visit megaphone.fm/adchoices
Greater transparency would go a long way to solve the deep institutional distrust people are feeling across most of government, media, and Corporate America. Our guest today, Mark Cuban, is tackling this transparency problem in the unnecessarily complex world of prescription drugs. We talked about the story behind CostPlusDrugs.com, his bold vision to “f–k up healthcare,” and lots about sports and family in between. Weigh in on our topical polls from the end of the episode below:Do you think playing multiple sports ultimately makes someone a better athlete? To what extent are you concerned about the privacy of your personal data when using AI systems like ChatGPT? What is your opinion of ketchup on eggs?Do you think it's possible to "have it all" as a working parent? Do you think it's a good or bad idea for middle and high school athletes to monetize their name, image, and likeness (NIL)?
Many entrepreneurs fail at investing for one simple reason: they say “yes” too much. In this episode, Erik Van Horn and Justin Donald break down the investor mindset, tax plays that compound, and how world-class networks unlock better terms, sponsors, and returns—plus the Guardian Bikes grand-slam story (featuring Mark Cuban). Timestamps: 00:00 – Why great investors say “no” 95% of the time 01:57 – Solar credits & how fast legislation changes 03:56 – Masterminds that pay for themselves 04:24 – Compounding: tax, education, deals 07:37 – Money-back guarantees from sponsors?! 11:06 – The real ROI of networks (vendors, sponsors, peers) 12:40 – Deal terms you should ask for: the “put option” 24:53 – How to spot outlier deals that look “the same” 46:56 – Family-office asset allocation (60/40 is dead) 50:44 – Build a non-emotional investment machine Resources Mentioned Website: lifestyleinvestor.com – free resources, masterclasses, masterminds, and courses Podcast: https://lifestyleinvestor.com/podcast/ Book: The Lifestyle Investor (updated & expanded edition) https://access.lifestyleinvestor.com/lifestyleinvestor-book?utm_source=website&utm_medium=organic&utm_campaign=redirect Free strategy call: lifestyleinvestor.com/consultation Connect with Erik Van Horn:
When rejection strikes, smart bets win. Mark Cuban knows that the biggest opportunities don't come from luck, they come from bold, calculated moves. In this episode of Hello Monday, Jessi Hempel sits down with Mark, the entrepreneur, investor, and Shark Tank star, to uncover how he turns setbacks into wins and spots opportunities before anyone else does. From negotiating high-stakes deals to pivoting careers in uncertain times, he shares the mindset and strategies that help him thrive when the future feels unpredictable. This conversation will leave you with tools to: Identify opportunities others overlook Make smarter bets that pay off Turn rejection and failure into momentum Negotiate with confidence and get what you're worth Stay resilient in a world that never stops changing Navigate career pivots, ageism, and salary conversations at any stage Don't just survive the changing world of work; learn how to turn uncertainty into your greatest advantage. Continue the conversation at Hello Monday Office Hours, Wednesdays at 3 PM ET on the LinkedIn News page. Watch the extended conversation with LinkedIn Premium.
Lindsay Mullenger turned a quiet moment of organizing her child's nursery into a Shark Tank–backed business. What started as a personal need for a meaningful keepsake box became Petite Keep, a company that won over Jamie Kern Lima, Mark Cuban, and Barbara Corcoran. From balancing a corporate career and motherhood to assembling products by hand with her family, she built her business with a mindset of “we figure it out.” Today, Lindsay runs a fast-growing company powered by community, storytelling, and a female-led team. Join us as we unpack her Shark Tank experience, the marketing strategies that fueled her growth, and the mindset shifts that every aspiring leader and entrepreneur can apply to transform a simple idea into something extraordinary. "Our core values are: be curious, grow every day, and own the outcome." ~ Lindsay Mullenger In This Episode: - The birth of Petite Keep - Balancing career, family, & a startup during the pandemic - Building the brand with influencer marketing - Family support to overcome fulfillment challenges - Quitting her job and the Shark Tank experience - The pitch and the deal with the sharks - Challenges growing the business - Future goals and vision for Petite Keep - Social media marketing strategies and being authentic Keep treasured memories alive with Petite Keep's personalized trunks! Shop now at: https://petitekeep.com/ About Lindsay Mullenger: Lindsay Mullenger is the founder and CEO of Petite Keep, a keepsake brand turning life's meaningful moments into heirloom treasures. A former brand builder and mom of five, Lindsay launched the company from her attic in 2020 and has since grown it into a nationally loved, eight-figure business rooted in heart, design, and intentional celebration. Website: https://petitekeep.com/ Instagram: https://www.instagram.com/lindsatpetitekeep/ Facebook: https://www.facebook.com/petitekeep/ Where to find me: IG: https://www.instagram.com/jen_gottlieb/ TikTok: https://www.tiktok.com/@jen_gottlieb Facebook: https://www.facebook.com/Jenleahgottlieb Website: https://jengottlieb.com/ My business: https://www.superconnectormedia.com/ YouTube: https://www.youtube.com/@jen_gottlieb
With nearly one in ten newborns in the US requiring care in a Neonatal Intensive Care Unit, the importance of NICUs has never been more clear. On today's episode of Raise the Line, we're shining a light on the extraordinary world of NICUs with Lindsay Howard, a veteran nurse with over 17 years of experience caring for premature and critically ill infants. She currently works in a Level IV NICU at Children's Memorial Hermann Hospital in Houston, one of the most advanced neonatal units in the country. “We call ourselves ‘the ER of the neonate world' because we're never full. We have to make space no matter what comes in off the street, and at the biggest medical center in the world, we see all the things,” she explains. In this enlightening conversation with host Lindsey Smith, Howard describes how advances in medicine have made it possible to provide more types of care for younger and smaller babies, creating a need for NICU nurses to develop subspecialties. In her case, Howard is on a dedicated team that handles the placement and maintenance of all central line IVs, and has earned certifications in neonatal and pediatric chemotherapy and biotherapies. “We see babies that we may not have seen before being born with cancerous tumors who need chemotherapy to try and eliminate it, or just give them more time with their family.” This is a revealing look inside the workings of a top tier NICU where you'll learn about approaches to care that support healthy neurodevelopment, how clinical staff handle the emotional challenges of the job, and how her own experience as a mother with twins needing NICU care impacted her work. Mentioned in this episode:Children's Memorial Hermann Hospital If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/raisethelinepodcast
NEW INTERVIEW: MARK CUBAN(:41) lowering prices at COST PLUS DRUGS(2:40) on Medicare for All (6:04) How Dems get health care wrong (7:19) Guaranteeing deductibles (10:28) “DID THEY VOTE FOR THIS?”(13:52) democracy in peril, do the rich care?(15:39) on income inequality(19:34) on taxing the rich (20:35) “The Trump health care tax”(21:54) media consolidation(23:21) messing with Kimmel may backfire (25:12) is Mark optimistic? (2 Americas)(27:11) Advice for Dems: Have action items (27:32) Zohran = opposite Trump?(29:08) focus on the “here & now”(29:33) James Talarico rocks (30:51) Mark likes the Holler
Wes Goldberg and guest Dieter Kurtenbach dissect the explosive Kawhi Leonard investigation, praising Pablo Torre's groundbreaking reporting. They scrutinize Adam Silver's tenure as NBA commissioner, questioning his focus on TV deals over league health. They explore innovative ways to enhance NBA strategy discussions, comparing coverage to the NFL and proposing new systems for describing team formations. All-Star Game format changes and ideas for boosting fan engagement round out this wide-ranging NBA analysis. Tune in for a critical look at the league's present and future, including potential consequences for cap circumvention and suggestions to revolutionize NBA media coverage. 0:00 Intro 3:42 Sports media's coverage of Kawhi scandal 15:41 NBA salary cap circumvention and punishment for alleged violations 20:30 League Dynamics and Player Influence: League control by top players 24:42 NBA Star Player Movement: Failure of acquiring star players 37:47 NBA Contracts and Team Flexibility 41:54 Coverage of Basketball vs. Other Sports 55:28 Sports broadcasting and game scheduling: Importance of structured game nights 1:03:52 Naming Defensive Formations 1:12:24 Mark Cuban's defense of Steve Ballmer 1:17:03 Ideas for All-Star weekend changes 1:22:00 The Take Wheel RealGM Radio is powered in part by North Station Media (CLNS). For advertising or media inquiries, contact info@clnsmedia.com
The process of applying to college can be so cumbersome and time consuming that applicants have little time left over for elaborate scholarship applications. Luckily, students can qualify for abundant merit aid just by excelling on admissions tests they should be prepping for anyway! Amy and Mike invited educator Shaan Patel to explore how to unlock automatic scholarships with PSAT, SAT, & ACT scores. What are five things you will learn in this episode? How directly do SAT and ACT scores translate into guaranteed scholarship money? How does the PSAT connect to the National Merit Scholarship program? What score ranges typically unlock the biggest automatic scholarships at public and private universities? How can families use their College 529 Savings Plans for test preparation? What are the most effective strategies for students to maximize both their scores and scholarship opportunities? MEET OUR GUEST Dr. Shaan Patel is the Founder and CEO of Prep Expert. On ABC's Shark Tank, he closed a deal with Mark Cuban for an investment in Prep Expert. He created Prep Expert to help high school students achieve their own dreams. Prep Expert has helped more than 100,000 students improve their SAT and ACT scores, get into top colleges, and win over $100 million in scholarships. Prep Expert offers online SAT and ACT courses, academic tutoring, and college admissions consulting. Shaan can be reached at prepexpert.com. LINKS Merit Aid Grids National Merit Scholarship RELATED EPISODES THE ROLE OF TEST SCORES IN COLLEGE MERIT AID FLORIDA BRIGHT FUTURES SCHOLARSHIP PSAT AND THE NATIONAL MERIT SCHOLARSHIP PROCESS FOUR SCHOLARSHIP MYTHS ABOUT THIS PODCAST Tests and the Rest is THE college admissions industry podcast. Explore all of our episodes on the show page. ABOUT YOUR HOSTS Mike Bergin is the president of Chariot Learning and founder of TestBright, Roots2Words, and College Eagle. Amy Seeley is the president of Seeley Test Pros and LEAP. If you're interested in working with Mike and/or Amy for test preparation, training, or consulting, get in touch through our contact page.
Episode 274 of The Business Development Podcast brings the inspiring journey of Dr. Juan Salinas, a food scientist, entrepreneur, and natural bodybuilder who defied the odds to create P-nuff Crunch, a plant-based protein snack that won the attention of Mark Cuban on Shark Tank. From his humble beginnings in Honduras to earning a PhD in food science from Rutgers and leading product innovations at Nestlé and Kraft, Dr. Salinas combined scientific expertise with his passion for health to revolutionize the snacking industry. His story highlights the grit, sacrifice, and relentless vision required to bring an innovative idea to life, even when it meant investing his life savings and building his own manufacturing facility.Throughout the conversation, Dr. Salinas shares insights on nutrition, obesity, and the mindset shifts needed to make healthier food choices, while also opening up about the challenges of entrepreneurship. From balancing bodybuilding with creating shelf-stable products, to enduring setbacks and pivots in scaling his company, he reveals the resilience behind every milestone. His Shark Tank experience—preparing in isolation during COVID, boldly negotiating with Cuban, and ultimately securing a deal—underscores the importance of preparation, courage, and belief in your mission. See his Shark Tank win here: https://www.youtube.com/watch?v=wp45o5i7zhE, Check out P-nuff Crunch here: https://www.pnuff.com/Key Takeaways: 1. Your background doesn't define your future—Dr. Salinas came from Honduras with little English and built a career as a PhD food scientist.2. Passion plus expertise creates innovation—combining bodybuilding and food science led him to invent P-nuff Crunch.3. Entrepreneurship requires sacrifice—he invested his life savings and took huge personal risks to build his company.4. Don't wait for permission—big corporations rejected his healthy snack ideas, so he built his own path.5. Manufacturing is a business itself—starting a facility taught him new challenges in HR, compliance, and operations.6. Preparation beats pressure—his Shark Tank success came from 10 days of focus, rehearsing every scenario until he was ready.7. Mindset is everything—he retrained his brain to crave healthier foods, just like quitting smoking.8. Strength training builds more than muscle—it increases metabolism and teaches discipline that carries into business.9. Adaptability keeps you alive—pivoting from “peanut puffs” to “protein puffs” kept his brand competitive.10. Divine timing matters—Mark Cuban's wife had tried P-nuff before the pitch, showing that hard work plus faith creates opportunities.If you listen to The Business Development Podcast, you belong in The Catalyst Club.
Listen to the full episode: https://www.youtube.com/watch?v=ThY-UBFtGK8 Even billionaires struggle with self-doubt. In this Fitness Friday excerpt from my conversation with Mark Cuban, he opens up about still feeling intimidated in rooms full of domain experts, why he believes most entrepreneurs hire the wrong people at the wrong time, and his surprising take on what business you're actually in. We also discuss his prediction for what will make cryptocurrency boom again and his unconventional take on why brand advertising is a waste of money for startups. Mark Cuban is a billionaire entrepreneur, owner of the Dallas Mavericks, and star investor on Shark Tank. Despite his success, he remains refreshingly honest about the psychological challenges of high-level business and the mistakes he's seen countless entrepreneurs make. What we discuss: Why Mark Cuban Still Gets Imposter Syndrome Around AI Experts The "Hamster Wheel" Hiring Mistake That Kills Startups Why He Says "You've Got to Be Able to Solve Problems Yourself" His Honest Take on Losing Money in the Voyager Crypto Collapse The Difference Between USD and USDC That Cost People Millions Why the NBA Thought They Were in the Wrong Business (And How He Fixed It) His Prediction for What Will Make Crypto Boom Again Why Brand Advertising is "Typically a Waste of Money" for Startups The Two Things Every Business Must Sell: Differentiation and Path of Least Resistance Thank you to our sponsor: Therasage: Head over to therasage.com and use code Be Bold for 15% off BiOptimizers: Want to try Magnesium Breakthrough? Go to https://bioptimizers.com/jennifercohen and use promo code JC10 at checkout to save 10% off your purchase. Timeline Nutrition: Get 10% off your first order at timeline.com/cohen Air Doctor: Go to airdoctorpro.com and use promo code HUSTLE for up to $300 off and a 3-year warranty on air purifiers. Find more from Mark Cuban: Instagram: https://www.instagram.com/mcuban/ Find more from Jen: Website: https://www.jennifercohen.com/ Instagram: @therealjencohen Books: https://www.jennifercohen.com/books Speaking: https://www.jennifercohen.com/speaking-engagements
As the NBA commissioner and the richest owner in sports dig in their heels, Pablo scoops up more Aspiration receipts — from Mark Cuban's tweets to the Clippers' C-suite and the cellphone of Uncle Dennis. Meanwhile, Dan Le Batard breaks character to look after a muckraker running on fumes.• Part III: The Mystery Investor, the No-Show Payday and the "Smoking Gun"• Part II: Team Ballmer vs. Team Sh*tting Bricks — an Argument with Mark Cuban• Part I: The Richest Owner in Sports, the Silent Superstar and the Rotten Apple Tree• Subscribe: Pablo's newsletter has exclusive access, documents and invites(Pablo Torre Finds Out is independently produced by Meadowlark Media and distributed by The Athletic. The views, research and reporting expressed in this episode are solely those of Pablo Torre Finds Out, and do not reflect the work or editorial input of The Athletic or its journalists.) Hosted on Acast. See acast.com/privacy for more information.
Today's show:On Friday's TWiST, Jason, Alex, and Lon look back at some highlights from this week's big All-In Summit in Los Angeles, including a fiery, no holds barred presentation from Palantir CEO Alex Karp, Elon Musk delving into the key challenges facing Optimus, and Tucker Carlson debating Mark Cuban on Ukraine. PLUS… why schools may start blocking social media apps, the FTC's new investigation into social chatbots, AND omnidirectional Zoox robotaxis are headed to Las Vegas.Timestamps:Welcome back to TWiST!(1:52) Jason's thoughts on the killing of Charlie Kirk(10:34) Squarespace - Use offer code TWIST to save 10% off your first purchase of a website or domain at https://www.Squarespace.com/TWIST(10:52) Show Continues …(12:15) Reacting to All-In Summit highlights (Elon Musk, Alex Karp, Tucker Carlson, Mark Cuban)(21:23) AWS Activate - AWS Activate helps startups bring their ideas to life. Apply to AWS Activate today to learn more. Visit https://www.aws.amazon.com/startups/credits(22:18) Show Continues …(26:09) Palantir, Alex Karp, and debate dynamics(31:03) Public - Take your investing to the next level with Public. Build a multi-asset portfolio and earn 4.1% APY on your cash—with no fees or minimums. Start now at public.com/twist(32:13) Show Continues …(45:03) How the internet used AI tools to make sense of Charlie Kirk's death(56:22) Why Jason thinks it's smart to block social media during school hours(1:03:43) The FTC chatbot investigation leaves out Anthropic's Claude… here's why(1:13:27) Zoox robotaxis make their Vegas debut… Here's how they're different from Waymo(1:19:38) Are Tesla robotaxis headed for CA soon? Polymarket says… maybe(1:27:21) Closing remarks and banterSubscribe to the TWiST500 newsletter: https://ticker.thisweekinstartups.comCheck out the TWIST500: https://www.twist500.comSubscribe to This Week in Startups on Apple: https://rb.gy/v19fcpFollow Lon:X: https://x.com/lonsFollow Alex:X: https://x.com/alexLinkedIn: https://www.linkedin.com/in/alexwilhelmFollow Jason:X: https://twitter.com/JasonLinkedIn: https://www.linkedin.com/in/jasoncalacanisThank you to our partners:Squarespace - Use offer code TWIST to save 10% off your first purchase of a website or domain at https://www.Squarespace.com/TWISTAWS Activate - AWS Activate helps startups bring their ideas to life. Apply to AWS Activate today to learn more. Visit https://www.aws.amazon.com/startups/creditsPublic - Take your investing to the next level with Public. Build a multi-asset portfolio and earn 4.1% APY on your cash—with no fees or minimums. Start now at public.com/twistGreat TWIST interviews: Will Guidara, Eoghan McCabe, Steve Huffman, Brian Chesky, Bob Moesta, Aaron Levie, Sophia Amoruso, Reid Hoffman, Frank Slootman, Billy McFarlandCheck out Jason's suite of newsletters: https://substack.com/@calacanisFollow TWiST:Twitter: https://twitter.com/TWiStartupsYouTube: https://www.youtube.com/thisweekinInstagram: https://www.instagram.com/thisweekinstartupsTikTok: https://www.tiktok.com/@thisweekinstartupsSubstack: https://twistartups.substack.comSubscribe to the Founder University Podcast: https://www.youtube.com/@founderuniversity1916
Listen to the full episode: https://www.youtube.com/watch?v=ThY-UBFtGK8 What if I told you Mark Cuban has invested over $100 million in companies from complete strangers who just sent him an email? In this Fitness Friday episode, I'm sharing insights from my conversation with Mark Cuban about his unconventional investment approach and the incredible companies built from cold outreach. We discuss how Cuban manages 200+ investments with just 12 team members, why he answers every single email personally, and the remarkable stories behind two of his biggest wins: a $4 billion space company and a revolutionary pharmacy that's disrupting Big Pharma. Mark Cuban is a billionaire entrepreneur, owner of the Dallas Mavericks, and star investor on Shark Tank who has built his reputation on being accessible to anyone with a compelling business idea. What we discuss: The $750K Investment That Became Worth "A Whole Lot of Money" at $4B Valuation Why Cuban Reads Every Email and Deletes Most in Under 2 Seconds How He Manages 200 Companies with Only 12 Employees The Cold Email Strategy That Led to Cost Plus Drugs Revolution Behind the Scenes of Shark Tank: Why 75% of His Deals Actually Close The Real Reason Most Shark Tank Entrepreneurs "Ghost" Their Deals How Cuban Turns Alyssa's Cookies Into a $20M Business With Zero Advertising Why He Refuses Meetings But Responds to Strangers' Emails Within Minutes The One Question Every Entrepreneur Must Ask: "Why Didn't I Think of That?" Thank you to our sponsor: Therasage: Head over to therasage.com and use code Be Bold for 15% off Air Doctor: Go to airdoctorpro.com and use promo code HUSTLE for up to $300 off and a 3-year warranty on air purifiers. Magic Mind: Head over to www.magicmind.com/jen and use code Jen at checkout. 99designs by Vista: 99designs.com/jen20 – click "Claim my discount" to get $20 off your first design contest. Momentous: Shop this link and use code Jen for 20% off Manna Vitality: Visit mannavitality.com and use code JENNIFER20 for 20% off your order Find more from Mark Cuban: Instagram: https://www.instagram.com/mcuban/ Find more from Jen: Website: https://www.jennifercohen.com/ Instagram: @therealjencohen Books: https://www.jennifercohen.com/books Speaking: https://www.jennifercohen.com/speaking-engagements
Bill O'Reilly is a political commentator and author of Confronting Evil: Assessing the Worst of the Worst, co-written with Josh Hammer. The book is available now, and you can follow him on X @BillOReilly and visit billoreilly.com. David Nihill is a comedian with a new special, Shelf Help, coming to YouTube September 11. Find more at davidnihill.com and follow him on Instagram and X @davidnihill.IN THE NEWS: Bruce Willis' wife defends moving him into his own home, Tucker Carlson clashes with Mark Cuban over Ukraine aid, Greta Thunberg's Gaza flotilla reportedly hit by a drone in Tunisia, and Charlie Sheen reveals liposuction in his new memoir.Get it on. FOR MORE WITH BILL O'REILLY:BOOK: CONFRONTING EVIL: Assessing the Worst of the WorstWEBSITE: billoreilly.comTWITTER: @billoreilly FOR MORE WITH DAVID NIHILL:SPECIAL: Shelf Help - Available on Youtube Sept 11 WEBSITE: DavidNihill.com INSTAGRAM & TWITTER: @davidnihillFOR MORE WITH JASON “MAYHEM” MILLER: INSTAGRAM & TWITTER: @mayhemmillerWEBSITE: www.mayhemnow.com Thank you for supporting our sponsors:BetOnlineHomes.comToday, get Huel for FIFTEEN PERCENT OFF with this exclusive offer for New Customers only with code adam15 at https://huel.com/adam15 (Minimum $75 purchase).Rosettastone.com/ADAMPluto.tvoreillyauto.com/ADAMLIVE SHOWS: Sept 26 - Albuquerque, NMSept 27 - Flagstaff, AZSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
(0:00) Introducing Mark Cuban, sadness over Luka Doncic (2:38) America's broken healthcare system (15:16) State of the two-party system (19:24) Introducing Tucker Carlson (20:01) The fine line between listening and pandering, is Mamdani the Trump of the Left? (24:27) How to make Americans believe in America again (34:12) AI job displacement (39:29) Lightning round with Tucker: Epstein, Putin, why the West is killing itself, the SSRI epidemic, Iryna Zarutska murder (52:54) Antisemitism and Israel Thanks to our partners for making this happen! Solana: https://solana.com/ OKX: https://www.okx.com/ Google Cloud: https://cloud.google.com/ IREN: https://iren.com/ Oracle: https://www.oracle.com/ Circle: https://www.circle.com/ BVNK: https://www.bvnk.com/ Follow Mark Cuban: https://x.com/mcuban Follow Tucker Carlson: https://x.com/TuckerCarlson Follow the besties: https://x.com/chamath https://x.com/Jason https://x.com/DavidSacks https://x.com/friedberg Follow on X: https://x.com/theallinpod Follow on Instagram: https://www.instagram.com/theallinpod Follow on TikTok: https://www.tiktok.com/@theallinpod Follow on LinkedIn: https://www.linkedin.com/company/allinpod Intro Music Credit: https://rb.gy/tppkzl https://x.com/yung_spielburg Intro Video Credit: https://x.com/TheZachEffect
"When I think of what a Journalist looks like, I think of Jim DeFede." So, we have to get to Mark Cuban joining Pablo Torre Finds Out and Steve Ballmer doing an interview in response to Pablo's reporting, but first, Dan ruins Football Friday by being brazenly anti-player while the Shipping Container breaks down The Second (and Third) Spitter™ from sports in the last week. Today's cast: Dan, Chris, Billy, Jeremy, Mike, and Roy. Learn more about your ad choices. Visit podcastchoices.com/adchoices
Listen to the full episode: https://www.youtube.com/watch?v=ThY-UBFtGK8 What does a billionaire's morning routine actually look like? In this Fitness Friday episode, I'm sharing an expert from my conversation with Mark Cuban about the daily habits and routines that fuel his billion-dollar empire. Tune in to discover why Mark sleeps only 5-6 hours but takes strategic naps, how he processes hundreds of emails daily while still prioritizing family time, and the surprising workout that helped him meet his wife. This isn't your typical morning routine - it's intentional living from someone who's built multiple billion-dollar companies. Mark Cuban is a billionaire entrepreneur, owner of the Dallas Mavericks, and star investor on Shark Tank. At 64, he maintains his competitive edge through basketball, Zumba classes, and a vegetarian diet while building companies that disrupt entire industries. What we discuss: Why Mark Cuban Wakes Up at Exactly 5:30 AM Every Day The Email Management System That Keeps Him Accessible to Anyone How He Balances Billion-Dollar Businesses with Being Present for His Kids Why He Refuses to Take Meetings or Phone Calls (and What He Does Instead) The Sleep Tracking Strategy That Maximizes His 5-6 Hour Nights The "Sales Cures All" Philosophy That Built His Empire How Strategic Napping Became Part of His Success Formula Thank you to our sponsor: Momentous: Shop this link and use code Jen for 20% off Therasage: Head over to therasage.com and use code Be Bold for 15% off TruNiagen: Head over to truniagen.com and use code HUSTLE20 to get $20 off any purchase over $100. Magic Mind: Head over to www.magicmind.com/jen and use code Jen at checkout. 99designs by Vista: 99designs.com/jen20 – click "Claim my discount" to get $20 off your first design contest. Find more from Mark Cuban: Instagram: https://www.instagram.com/mcuban/ Find more from Jen: Website: https://www.jennifercohen.com/ Instagram: @therealjencohen Books: https://www.jennifercohen.com/books Speaking: https://www.jennifercohen.com/speaking-engagements
Today's word of the day is ‘untoward' as in inconvenient as in unexpected and inappropriate as in the Clippers as in the NBA as in Pablo Torre as in Mark Cuban. We have a ton of updates from the PTFO episode that was released yesterday. The Clippers say it was false. Cuban says Ballmer would never! But the reporting is the reporting! (20:40) Now we get to Mark Cuban. (33:30) Review: The War of the Roses. (37:40) Roman Anthony is hurt. Not good! (43:40) The New York Mets have two major problems. Pitching and pitching. (48:40) NPPOD. Learn more about your ad choices. Visit podcastchoices.com/adchoices